Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Company Profile and bullboard matches:

TXMD , T.HLS , T.CTX , T.GUD , V.XRTX , T.CRDL , T.APLI
Sort by: Date|Relevance

BioNTech & Cardiol Therapeutics – on the verge of a breakout

Compared with the broader indices, DAX and Dow Jones, which have already reached new all-time highs, the Nasdaq Biotech Index is currently lagging. The sector index is still around 23% below its peak from August 2021. Nevertheless, the sector is on the move. In addition t...
Stefan Feulner | May 22, 2024 |

Takeover rumours: BioNTech, Cardiol Therapeutics and Novo Nordisk in focus

The biotech sector has significantly lagged behind the performance of artificial intelligence and high-tech this year. This is because of high inflation, which in turn has made an imminent interest rate cut unlikely. Nevertheless, Germany’s economic condit...
André Will-Laudien | April 24, 2024 |

BASF and Cardiol Therapeutics recommended buys; TUI rides momentum

BASF (OTCQX:BASFY) shares have gained over 30% within six months. But is the rally in BASF shares slowly running out of steam? The fact that the stock did not rise sharply yesterday despite a significant price target increase suggests this is the case. Many experts see ...
Fabian Lorenz | April 10, 2024 |

Take a closer look at HelloFresh, Bayer and Altech Advanced Materials

Bayer shares gained around 7 per cent last week. Is this the turnaround after the stock reached a multi-year low? Altech Advanced Materials stock is also working on an upward trend. The German battery hopeful has published a promising feasibility study. Their stationary s...
Fabian Lorenz | April 5, 2024 |

NetraMark Holdings, bridging an important pharmaceutical industry gap

NetraMark Holdings is a tech company, looking to identify and fill current gaps in the pharmaceutical industry. The Toronto-based company offers its proprietary algorithms to change the way in which Artificial Intelligence is used in the field, uncovering insights fro...
Simon Druker | April 27, 2023 |

AMPD is leading the transition to the next generation of computing infrastructure

Welcome to the Market Herald Top Line. I’m Brieanna McCutcheon, reporting from Downtown Vancouver. AMPD is a next-generation infrastructure company looking to reinvent the internet to support low-latency applications in an environmentally conscious w...
Brieanna McCutcheon | September 29, 2022 |

Why This Psychedelics Company is Focused on Weight Management

Psychedelics are transforming so many aspects of our everyday lives — from treating mental health conditions to weight management and obesity. Companies like NeonMind Biosciences ( CSE:NEON , OTCQB:NMDBD , Forum ) are at the forefront of this innovation ...
Jocelyn Aspa | May 4, 2022 |

Unlocking the Healing Potential of Safe, Natural Psychedelics

When we last caught up with Filament Health Corp. ( NEO.FH , Forum ) and their CEO and Co-Founder, Ben Lightburn last July , our Stockhouse investors were introduced to an industry leader in exclusively-natural psychedelic drug discovery and extraction. The company enga...
Dave Jackson | April 11, 2022 |

A Company on a Mission to Revolutionize Mental Healthcare. Here’s How.

When Stockhouse Editorial last caught up with Cybin Inc. ( NEO.CYBN , NYSE: CYBIN , Forum ) back in October, our audience learned about a leading biotechnology company focused on researching and progressing psychedelic therapeutics by utilizing proprietary drug discover...
Dave Jackson | January 31, 2022 |

Buzz on the Bullboards: New Year, New Stocks?

The beginning of a new year always sparks hope and signals new possibilities — and that same logic can be applied to the stock market. 2021 certainly had its plethora of ups and downs, but the Canadian market finished off the year strong and the sentiment remains bul...
Stockhouse Editorial | January 5, 2022 |
1 2 3 4 5 6 7 8 9 10 ...